PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10438951-5 1999 The present study shows that the synthetic glucocorticoid, dexamethasone, inhibits the induction of the proinflammatory cytokine IL-8 and the adhesion molecules VCAM-1 and ICAM-1 in human 1321N1 astrocytoma and SK.N.SH neuroblastoma cells. Dexamethasone 59-72 vascular cell adhesion molecule 1 Homo sapiens 161-167 8548848-0 1996 Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Dexamethasone 113-126 vascular cell adhesion molecule 1 Homo sapiens 69-75 9796922-6 1998 We demonstrate that FN and VCAM-1 (both of which bind alpha4beta1 integrin), but not collagen, considerably augment TCR-mediated protection of thymocytes from Dex-induced apoptosis. Dexamethasone 159-162 vascular cell adhesion molecule 1 Homo sapiens 27-33 8849372-9 1996 Dexamethasone inhibited both VCAM-1 and ICAM-1 surface and mRNA expression in a dose-dependent manner, which correlated with the inhibition of lymphocyte adhesion. Dexamethasone 0-13 vascular cell adhesion molecule 1 Homo sapiens 29-35 34359331-7 2021 In the cohort who had received one dexamethasone dose, non-survivors had higher ICU admission levels of only soluble (s) vascular cell adhesion molecule-1 (VCAM-1), soluble urokinase-type plasminogen activator receptor (suPAR) and presepsin. Dexamethasone 35-48 vascular cell adhesion molecule 1 Homo sapiens 121-154 7694584-0 1993 Effect of dexamethasone, 6-mercaptopurine and cyclosporine A on intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. Dexamethasone 10-23 vascular cell adhesion molecule 1 Homo sapiens 102-135 8548848-7 1996 Dexamethasone had strong suppressive effects on ICAM-1 (P < 0.001), E-selectin (P < 0.0001), and VCAM-1 (P < 0.0002). Dexamethasone 0-13 vascular cell adhesion molecule 1 Homo sapiens 103-109 34359331-7 2021 In the cohort who had received one dexamethasone dose, non-survivors had higher ICU admission levels of only soluble (s) vascular cell adhesion molecule-1 (VCAM-1), soluble urokinase-type plasminogen activator receptor (suPAR) and presepsin. Dexamethasone 35-48 vascular cell adhesion molecule 1 Homo sapiens 156-162 15665055-9 2005 VCAM-1, ICAM-1, and vasoocclusion increased significantly 3 days after dexamethasone discontinuation, possibly explaining rebounds in vasoocclusive crises observed after withdrawal of glucocorticosteroids in sickle patients. Dexamethasone 71-84 vascular cell adhesion molecule 1 Homo sapiens 0-6 16291414-9 2005 CONCLUSION: In this study, dexamethasone-eluting stents reduced plasma concentrations of ICAM-1 and VCAM-1 after PCI in patients with unstable coronary syndromes compared with historical controls. Dexamethasone 27-40 vascular cell adhesion molecule 1 Homo sapiens 100-106 33203447-10 2020 In network analysis, NGF, PI3KR1, and VCAM1 were identified as central genes among those most strongly affected by dexamethasone. Dexamethasone 115-128 vascular cell adhesion molecule 1 Homo sapiens 38-43 26454448-10 2016 Stimulation of HUVECs with MSU crystals increased expression of VCAM-1 and ICAM-1, which were markedly inhibited by both rebamipide and dexamethasone. Dexamethasone 136-149 vascular cell adhesion molecule 1 Homo sapiens 64-70 19032233-8 2008 TNF-alpha-induced GRO-alpha and IL-8 were slightly attenuated by DEX treatment (reaches to 89% and 79%, respectively), whereas expressions of IP-10, ICAM-1 and VCAM-1 were significantly enhanced by the same treatment (up to 172%, 152% and 139%, respectively). Dexamethasone 65-68 vascular cell adhesion molecule 1 Homo sapiens 160-166 11459775-3 2001 We therefore examined the effects of the PPARalpha activator fenofibrate and the GR activator dexamethasone on TNFalpha-stimulated expression of IL-6 and vascular cell adhesion molecule-1 in vascular endothelial cells. Dexamethasone 94-107 vascular cell adhesion molecule 1 Homo sapiens 154-187 12370131-4 2002 Dexamethasone showed significant inhibition of cytokine-induced ICAM-1 expression in HMEC-1, and E-selectin, VCAM-1 and ICAM-1 expressions in HUVEC. Dexamethasone 0-13 vascular cell adhesion molecule 1 Homo sapiens 109-115 10477680-13 1999 Our investigations also provide a rationale for the therapeutic use in ACS of cytoprotective modulators including NO and dexamethasone, which potentially exert their efficacy by an inhibitory effect on VCAM-1 and concomitant inhibition of sickle erythrocyte-endothelial adhesion. Dexamethasone 121-134 vascular cell adhesion molecule 1 Homo sapiens 202-208 11408765-6 2001 The effects of dexamethasone on the expression of VCAM-1 and ICAM-1 on HPMEC were examined by cell ELISA. Dexamethasone 15-28 vascular cell adhesion molecule 1 Homo sapiens 50-56 10884367-4 2000 Dex, but not E(2), stabilized VCAM-1 mRNA. Dexamethasone 0-3 vascular cell adhesion molecule 1 Homo sapiens 30-36